9996 — Peijia Medical Cashflow Statement
0.000.00%
Last trade - 00:00- HK$4.12bn
- HK$3.99bn
- CNY712.87m
Annual cashflow statement for Peijia Medical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -574 | -398 | -392 | -222 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 51.7 | -113 | -4.45 | 6.31 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 58.6 | 99.3 | -230 | 151 | — |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -436 | -376 | -583 | -5.18 | — |
| Capital Expenditures | -201 | -202 | -316 | -280 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -223 | -261 | -70.1 | 140 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -425 | -463 | -386 | -140 | — |
| Financing Cash Flow Items | -4.07 | -2.81 | -6.01 | 9.6 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 742 | 117 | 85.1 | 10.4 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -162 | -626 | -874 | -129 | — |